MyFinsight
Home
Compare
About
Recent SEC Filings
10/6
Lamb Weston Holdings, Inc.
(LW)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/6
Lamb Weston Holdings, Inc.
(LW)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Income Overview
Revenue
$6,314K
Net Income
-$67,255K
Net Profit Margin
-1065.17%
EPS
-$0.52
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
Collaboration revenue
6,314
7,224
Research and development
64,330
57,812
General and administrative
13,598
13,524
Total operating expenses
77,928
71,336
Loss from operations
-71,614
-64,112
Change in fair value of convertible preferred stock warrant liability
0
363
Interest expense
155
182
Interest income
4,629
2,913
Foreign currency exchange loss
-62
58
Total other income (expense), net
4,412
2,426
Loss before provision for income taxes
-67,202
-61,686
Provision for income taxes
53
28
Net loss
-67,255
-61,714
Net loss attributable to non-controlling interests
0
-268
Net loss attributable to generate biomedicines, inc. stockholders
-67,255
-61,446
Convertible preferred stock accrued dividends
0
7,749
Net loss attributable to generate biomedicines, inc. common stockholders
-67,255
-69,195
Basic EPS
-0.52
-1.07
Diluted EPS
-0.52
-1.07
Basic Average Shares
128,240,371
64,871,295
Diluted Average Shares
128,240,371
64,871,295
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
GENB Income Statement Sankey Diagram
Sankey diagram visualizing GENB income statement for the period
Net loss
attributable to generate...
-$67,255K
Net loss
attributable to generate...
-$67,255K
Net loss
-$67,255K
Interest income
$4,629K
Loss before
provision for income taxes
-$67,202K
Provision for income taxes
$53K
Total other income
(expense), net
$4,412K
Interest expense
$155K
Foreign currency
exchange loss
-$62K
Loss from operations
-$71,614K
Collaboration revenue
$6,314K
Total operating
expenses
$77,928K
Research and development
$64,330K
General and
administrative
$13,598K
Buy us a coffee
Generate Biomedicines, Inc. (GENB)
Generate Biomedicines, Inc. (GENB)